Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Zhong‐Sheng Tong"'
Autor:
Jin-Hu Fan, Su Zhang, Huan Yang, Zong-Bi Yi, Qu-Chang Ouyang, Min Yan, Xiao-Jia Wang, Xi-Chun Hu, Ze-Fei Jiang, Tao Huang, Zhong-Sheng Tong, Shu-Sen Wang, Yong-Mei Yin, Hui Li, Run-Xiang Yang, Hua-Wei Yang, Yue-E. Teng, Tao Sun, Li Cai, Hong-Yuan Li, Xue-Nong Ouyang, Jian-Jun He, Xin-Lan Liu, Shun-E. Yang, Jia-Yu Wang, Bing-He Xu, You-Lin Qiao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThis study aimed to explore possible associations between molecular subtypes and site of distant metastasis in advanced breast cancer (ABC).Methods3577 ABC patients were selected from 21 hospitals of seven geographic regions in China from 20
Externí odkaz:
https://doaj.org/article/d59fc4f00f5042a8a6ce6d73845e9301
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 1, Iss 1, Pp 27-35 (2015)
Objectives: This article reviews pharmacology, pharmacokinetic properties, clinical efficacy, and safety in metastatic breast cancer patients, as well as the predictive biomarkers for outcome of treatment with pemetrexed-based regimens. Methods: PubM
Externí odkaz:
https://doaj.org/article/0e85f4e739c54bea9d4344b05a6e51e9
Autor:
Ye-Hui Shi, Dong-Fang Dai, Jing Li, Yan-Wei Dong, Yin Jiang, Huan-Gong Li, Yuan Gao, Chuan-Ke Chong, Hui-Ying Li, Xiao-Qian Chu, Cheng Yang, Quan Zhang, Zhong-Sheng Tong, Cui-Gai Bai, Yue Chen
Publikováno v:
Molecules, Vol 21, Iss 4, p 514 (2016)
Recent studies have shown that sulforaphane (SFN) selectively inhibits the growth of ALDH+ breast cancer stem-like cells.Herein, a series of SFN analogues were synthesized and evaluated against breast cancer cell lines MCF-7 and SUM-159, and the leuk
Externí odkaz:
https://doaj.org/article/5c0fc2e80acc47ed821e970524da7672
Publikováno v:
Inorganica Chimica Acta. 554:121572
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d95c51a37c39b20aaf9ffc7606417c8a
https://doi.org/10.1016/j.ica.2023.121572
https://doi.org/10.1016/j.ica.2023.121572
Autor:
Jun‐Min Zhang, Yuping Ran, Xun Zhou, Yu Zhang, Palida Abliz, Aiping Wang, Weida Liu, Yu-Zhen Li, Min Zhu, Nan Yu, Zhong‐Sheng Tong, Jin Yu, Ruoyu Li, Lian‐Juan Yang, Cunwei Cao, Fuqiu Li
Publikováno v:
Mycoses. 63:1235-1243
Background In China, the prevalence of superficial fungal infections of the foot is high and recurrence is common. However, a prospective, large-scale and multicentre study on the aetiology of superficial fungal infections of the foot is still lackin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a0d358a500b234547d98fa994420f1
https://doi.org/10.1111/myc.13168
https://doi.org/10.1111/myc.13168
Autor:
Huan Yang, Qu-Chang Ouyang, Min Yan, Xiao-Jia Wang, Xi-Chun Hu, Ze-Fei Jiang, Tao Huang, Zhong-Sheng Tong, Shu-Sen Wang, Yong-Mei Yin, Hui Li, Run-Xiang Yang, Hua-Wei Yang, Yue-E Teng, Tao Sun, Li Cai, Hong-Yuan Li, Xue-Nong Ouyang, Jian-Jun He, Xin-Lan Liu, Shun-E Yang, Jin-Hu Fan, Jia-Yu Wang, You-Lin Qiao, Bing-He Xu
Publikováno v:
Annals of translational medicine. 10(15)
Several studies have indicated possible associations between age and the prognosis of breast cancer (BC), but limited data are available from hospital-based multicenter studies in China. This study aimed to explore the associations between age at ini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd0b62f4bbec8801b9976d75a0c39ce
https://pubmed.ncbi.nlm.nih.gov/36034985
https://pubmed.ncbi.nlm.nih.gov/36034985
Autor:
Xin Hong Wu, Hai Dong Chi, Ying Cheng, Min Yan, Zhong Sheng Tong, Hui Ping Li, Ze Fei Jiang, Yi Lu, Man Li, Xi Chen, Tao Sun, Qu Chang Ouyang, Ning Liao, G.B. Kanakasetty, Yong Mei Yin, Yunpeng Liu, Xi Chun Hu, Roberto Hegg, Xiao Jia Wang, Ru Bing Han, Ji Feng Feng, Maria A. Coccia-Portugal, Romulo Costa, Christina Pimentel Oppermann, Q. Zhang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Aim:To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET) versus ET alone in postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::618ab9aac2f18954d1d66f37dbd4a030
https://doaj.org/article/97a1aeef27ca442790bae5374547f9e7
https://doaj.org/article/97a1aeef27ca442790bae5374547f9e7
Autor:
Yong Sheng Jia, Shi Qi Bao, Ye Hui Shi, Wen Ping Lu, Xiao Han Jin, Zhong Sheng Tong, Qiu Ying Li
Publikováno v:
Journal of Cellular Biochemistry. 120:1386-1397
Endocrine therapy is one of the main treatments for estrogen receptor-positive breast cancers. Tamoxifen is the most commonly used drug for endocrine therapy. However, primary or acquired tamoxifen resistance occurs in a large proportion of breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78750acfc181324621d1741cfa05aae1
https://doi.org/10.1002/jcb.27146
https://doi.org/10.1002/jcb.27146
Autor:
Dong Geng Liu, Jiong Wu, Zhi Min Shao, Yue Yin Pan, Ji Feng Feng, Yue E. Teng, Jian Feng Luo, Gu Yin Lou, Yong Mei Yin, Xi Chun Hu, Xiao Jia Wang, Chang Ping Wu, Bi Yun Wang, Zhong Sheng Tong, Ze Fei Jiang, Ya Jia Gu, Kang Sun, Li Cai, Joseph Ragaz, Bing He Xu, Zhong Hua Wang, Jian Zhang
Publikováno v:
The Lancet Oncology. 16:436-446
Summary Background Platinum chemotherapy has a role in the treatment of metastatic triple-negative breast cancer but its full potential has probably not yet been reached. We assessed whether a cisplatin plus gemcitabine regimen was non-inferior to or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb1956a114d6cb9a491914563324b2c
https://doi.org/10.1016/s1470-2045(15)70064-1
https://doi.org/10.1016/s1470-2045(15)70064-1
Autor:
Can Lu, Yong Sheng Jia, Li Yan Zhou, Xing Yu Chen, Zhong Sheng Tong, Yue Chen, Hui Jun Xu, Xiaodong Liu
Publikováno v:
Acta Pharmacologica Sinica. 35:929-936
Receptor-interacting protein 3 (RIP3) is involved in tumor necrosis factor receptor signaling, and results in NF-κB-mediated prosurvival signaling and programmed cell death. The aim of this study was to determine whether overexpression of the RIP3 g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ea378160895ec054ed1862c3c0b065
https://doi.org/10.1038/aps.2014.31
https://doi.org/10.1038/aps.2014.31